MyAverix Finance
NS · Pharmaceuticals
Aarti Drugs Ltd (AARTIDRUGS)
Pharmaceuticals & Biotechnology
Aarti Drugs Ltd (AARTIDRUGS) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $34.19B, P/E ratio is 20.20, net margin is 7.0%, dividend yield is 0.53%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for AARTIDRUGS
Aarti Drugs Ltd (AARTIDRUGS) — FAQ
What is Aarti Drugs Ltd's market cap?
Aarti Drugs Ltd (AARTIDRUGS) has a reported market cap of $34.19B (data as of 2026-07-10).
What is AARTIDRUGS's P/E ratio?
The price-to-earnings (P/E) ratio for Aarti Drugs Ltd (AARTIDRUGS) is 20.20 (data as of 2026-07-10).
Does Aarti Drugs Ltd pay a dividend?
Aarti Drugs Ltd (AARTIDRUGS) shows a reported dividend yield of 0.53%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).
What sector is Aarti Drugs Ltd in?
Aarti Drugs Ltd (AARTIDRUGS) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is AARTIDRUGS listed on?
AARTIDRUGS is listed on NS.
What is Aarti Drugs Ltd's net margin?
Aarti Drugs Ltd (AARTIDRUGS) reports a net margin of 7.0% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.